by Darshan Kulkarni | Mar 30, 2017 | Pharmacy
With the opioid crisis becoming as problematic as it has been, the State of New Jersey has enacted new legislation that limits the initial opioid prescription to a 5 day supply (instead of 7 days like many other states). This would not apply in cases like end of life...
by Darshan Kulkarni | Mar 23, 2017 | Pharmacy
I just saw this in the news and thought of you. As you know, various states are working to expand the role of pharmacists including by testing patients. Texas is about to go a step further and allow pharmacists to complete an ACPE authorized training program and then...
by Darshan Kulkarni | Mar 16, 2017 | Compounding, Drugs, Pharmacy
As you may be aware, the State Board of Pharmacy in Pennsylvania has decided to update its compounding regulations and synchronize them with US FDA regulations. We are currently in the 30 day comment period. If you have questions about what this means to you , please...
by Darshan Kulkarni | Aug 16, 2016 | FDA, Pharmacy
Introduction The recent spate of FDA activity has resulted in the need for pharmacies to understand how to adequately respond to the FDA and the public shaming (or more) that may ensue if companies do not meet FDA expectations. Case Presentation: It is routine for the...
by Darshan Kulkarni | Aug 9, 2016 | Advertising, Pharmacy
Introduction While a huge area of focus for pharmacies has been violations in making misbranded and/or adulterated products, most ignore violative marketing arrangements between pharmacies and other healthcare companies/professionals. However, these marketing...
Recent Comments